Navigation Links
Medicine, energy topics of Kavli lectures at American Chemical Society meeting
Date:6/6/2013

One scientist is pioneering a new field in medicine curing diseases by replacing the missing proteins that cause certain disorders, almost like an artificial limb replaces the function of a leg or arm lost to injury. Another is an internationally known leader in science on the cusp of chemistry and biology who focuses on using artificial photosynthesis to make energy from sunlight and water.

They will deliver the next talks in the Kavli Foundation Lecture series at the 246th National Meeting & Exposition of the American Chemical Society (ACS), the world's largest scientific society. ACS announced today that Martin D. Burke, M.D., Ph.D., and Harry Gray, Ph.D., will deliver the lectures at the meeting. More than 10,000 scientists and others are expected for the event, which will include about 7,200 reports on new discoveries in science and other topics.

Burke is an associate professor of chemistry and a Howard Hughes Medical Institute early career scientist at the University of Illinois at Urbana-Champaign. He will deliver "The Kavli Foundation Emerging Leader in Chemistry Lecture" on Monday, Sept. 9, 2013, at 4 p.m., in the Indiana Convention Center.

He is a pioneer in the emerging field of "molecular prosthetics," which seeks to treat currently incurable medical conditions caused by missing proteins or proteins that don't work normally. The goal is development of medications that would travel to the site of the missing or malfunctioning protein, and do its work.

Gray is the Arnold O. Beckman Professor of Chemistry and founding director of the Beckman Institute at the California Institute of Technology. He will deliver "The Kavli Foundation Innovations in Chemistry Lecture" on Monday, Sept. 9, 2013, at 5:30 p.m., in the Indiana Convention Center.

He is making strides in developing more affordable catalysts that would replicate the natural process that plants use to make energy from sunlight and water. Gray pioneered a new field of science that combines chemistry and biology and includes such research. He has published more than 800 research papers and 18 books and received numerous awards.

The two lecture series are a result of collaboration between ACS and The Kavli Foundation, an internationally recognized philanthropic organization known for its support of basic scientific innovation.

"The Kavli Foundation Innovations in Chemistry Lecture" series debuted at the Anaheim meeting in March 2011 and will continue through 2013. They address the urgent need for vigorous, new, "outside-the-box" thinking, as scientists tackle many of the world's mounting challenges, like climate change, emerging diseases and water and energy shortages.

"The Kavli Foundation Emerging Leader in Chemistry Lecture" series recognizes the achievements of outstanding young chemical scientists. These presentations feature exceptional scientists younger than 40 years old and not more than 10 years removed from earning their Ph.D.s when nominated.

"The Foundation is delighted to partner on this series, which provides an important platform for vital young scientists whose research is pioneering their fields, often in ways in ways that are impacting the traditional boundaries of science," said Kavli Foundation President Robert W. Conn, Ph.D.

Marinda Li Wu, Ph.D., 2013 ACS president, praised The Kavli Foundation for its support of the lectures and leadership on a broad range of other activities in advancing science. "The Kavli Foundation and the American Chemical Society are excellent partners with remarkably similar missions," Wu said. "I am delighted that these two organizations can work together in their dedication to achieving these goals."


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Related biology news :

1. After the Genome tackles tough questions about medicine, miracles and morality
2. Young malaria parasites refuse to take their medicine, may explain emerging drug resistance
3. Personalized health care will revolutionize 21st century medicine, says NJIT professor
4. University of Maryland School of Medicine, NIH study pinpoints brain areas role in learning
5. Study finds disincentives to energy efficiency can be fixed
6. New logistics services that will cut energy consumption and CO2 emissions
7. Energy supply from hydropower projects depends on rainforest conservation
8. Setting the standard for sustainable bioenergy crops
9. $1 million for smart energy solutions
10. Energy efficiency could increase infection risks in hospital wards
11. Women with HIV shown to have elevated resting energy expenditure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology: